<HashMap><database>GEO</database><scores/><additional><omics_type>Transcriptomics</omics_type><species>Homo sapiens</species><gds_type>Expression profiling by high throughput sequencing</gds_type><full_dataset_link>https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE312194</full_dataset_link><repository>GEO</repository><entry_type>GSE</entry_type></additional><is_claimable>false</is_claimable><name>MEK inhibition induces AXIN1 loss in colorectal cancer by mTOR associated suppression of protein synthesis [RNASeq_HCT116]</name><description>AXIN1 is a central regulatory hub of many oncogenic pathways in colorectal cancer (CRC). As the main scaffold protein and least abundant component of the beta-catenin destruction complex, changes in AXIN1 levels affect Wnt signaling output. We show that targeting the Ras-MAPK pathway by MEK1/2 inhibitors induces AXIN1 loss across a panel of CRC cell lines and patient-derived organoids. GSK3B inhibition similarly reduced AXIN1 levels, yet by distinct mechanisms. MEK1/2 causes a reduction of AXIN1 transcript levels, but neither affects protein stability nor post-translational modifications of AXIN1. In contrast, GSK3B inhibition induces rapid AXIN1 degradation. Prevention of AXIN1 loss by co-treatment with tankyrase inhibitors was much stronger for GSK3B than for MEK1/2 inhibition. Using isogenic CRC cell lines and murine intestinal organoids, we show that APC truncations strongly reduce basal AXIN1 levels, but do not alter dynamics of AXIN1 loss upon MEK1/2 inhibition. Polysome profiling and Ribo-Seq revealed that MEK1/2 inhibition reduces global protein synthesis via an mTOR dependent pathway. This translational repression is sufficient to cause significant AXIN1 loss, as treatment with mTOR inhibitors phenocopies the effect of MEK1/2 inhibitors. Our study demonstrates that AXIN1 protein homeostasis is critically controlled by Ras-MAPK signaling at the level of protein synthesis, and that MEK1/2 inhibitors cause AXIN1 loss by translational repression.</description><dates><publication>2026/06/03</publication></dates><accession>GSE312194</accession><cross_references><GSM>GSM9340203</GSM><GSM>GSM9340204</GSM><GSM>GSM9340201</GSM><GSM>GSM9340202</GSM><GSM>GSM9340188</GSM><GSM>GSM9340189</GSM><GSM>GSM9340200</GSM><GSM>GSM9340209</GSM><GSM>GSM9340207</GSM><GSM>GSM9340208</GSM><GSM>GSM9340205</GSM><GSM>GSM9340206</GSM><GSM>GSM9340195</GSM><GSM>GSM9340196</GSM><GSM>GSM9340193</GSM><GSM>GSM9340194</GSM><GSM>GSM9340191</GSM><GSM>GSM9340192</GSM><GSM>GSM9340190</GSM><GSM>GSM9340214</GSM><GSM>GSM9340212</GSM><GSM>GSM9340213</GSM><GSM>GSM9340210</GSM><GSM>GSM9340199</GSM><GSM>GSM9340211</GSM><GSM>GSM9340197</GSM><GSM>GSM9340198</GSM><GPL>24676</GPL><GSE>312194</GSE><taxon>Homo sapiens</taxon><PMID>[42204589]</PMID></cross_references></HashMap>